Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes.
Irlik K, Aldosari H, Hendel M, Kwiendacz H, Piaśnik J, Kulpa J, Ignacy P, Boczek S, Herba M, Kegler K, Coenen F, Gumprecht J, Zheng Y, Lip GYH, Alam U, Nabrdalik K. Irlik K, et al. Among authors: nabrdalik k. Diabetes Obes Metab. 2024 Apr 11. doi: 10.1111/dom.15578. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38603589
Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry.
Bucci T, Nabrdalik K, Shantsila A, Romiti GF, Teo WS, Park HW, Shimizu W, Tse HF, Proietti M, Chao TF, Lip GYH, Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators. Bucci T, et al. Among authors: nabrdalik k. J Clin Med. 2024 Feb 23;13(5):1274. doi: 10.3390/jcm13051274. J Clin Med. 2024. PMID: 38592107 Free PMC article.
Effect of combination pioglitazone with sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta-analysis, and real-world study from an international federated database.
Anson M, Henney AE, Zhao SS, Ibarburu GH, Lip GYH, Cuthbertson DJ, Nabrdalik K, Alam U. Anson M, et al. Among authors: nabrdalik k. Diabetes Obes Metab. 2024 Apr 1. doi: 10.1111/dom.15576. Online ahead of print. Diabetes Obes Metab. 2024. PMID: 38558280
Cardiovascular Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetes: A Real-World Data Analysis.
Lai JYM, Riley DR, Anson M, Henney A, Cuthbertson DJ, Hernadez G, Austin P, Lip GYH, Zhao SS, Jackson TL, Nabrdalik K, Alam U. Lai JYM, et al. Among authors: nabrdalik k. Diabetes Ther. 2024 Apr;15(4):833-842. doi: 10.1007/s13300-024-01544-3. Epub 2024 Feb 24. Diabetes Ther. 2024. PMID: 38407774 Free PMC article.
Machine learning identification of risk factors for heart failure in patients with diabetes mellitus with metabolic dysfunction associated steatotic liver disease (MASLD): the Silesia Diabetes-Heart Project.
Nabrdalik K, Kwiendacz H, Irlik K, Hendel M, Drożdż K, Wijata AM, Nalepa J, Janota O, Wójcik W, Gumprecht J, Lip GYH. Nabrdalik K, et al. Cardiovasc Diabetol. 2023 Nov 20;22(1):318. doi: 10.1186/s12933-023-02014-z. Cardiovasc Diabetol. 2023. PMID: 37985994 Free PMC article.
57 results